Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder that causes debilitating swelling and destruction of the joints. People with RA are treated with drugs that actively suppress one or more parts of their immune system, and these may alter the response to vaccination against SARS...
Main Authors: | Samuel D. Klebanoff, Lauren B. Rodda, Chihiro Morishima, Mark H. Wener, Yevgeniy Yuzefpolskiy, Estelle Bettelli, Jane H. Buckner, Cate Speake, Marion Pepper, Daniel J. Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-08-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.168663 |
Similar Items
-
Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis
by: Jing Song, et al.
Published: (2021-03-01) -
STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation
by: Carlos A. Arbelaez, et al.
Published: (2022-06-01) -
Mechanism‐driven strategies for prevention of rheumatoid arthritis
by: V. Michael Holers, et al.
Published: (2022-09-01) -
Auto-Immune Pancreatitis in Rheumatoid Arthritis
by: Oguzhan Yildirim, et al.
Published: (2015-06-01) -
Rheumatoid arthritis-associated rheumatoid factors post-COVID-19
by: Adam H. Titi, et al.
Published: (2025-02-01)